Related Experiment Video
Updated: Jun 27, 2026

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol
Kwang-Hoon Song1, Tiangang Li, Erika Owsley
1Department of Integrative Medical Sciences, Northeastern Ohio Universities Colleges of Medicine and Pharmacy, Rootstown, OH 44272, USA.
Unlabelled:
Mouse fibroblast growth factor 15 (FGF15) and human ortholog FGF19 have been identified as the bile acid-induced intestinal factors that mediate bile acid feedback inhibition of cholesterol 7alpha-hydroxylase gene (C YP7A1) transcription in mouse liver. The mechanism underlying FGF15/FGF19 inhibition of bile acid synthesis in hepatocytes remains unclear. Chenodeoxycholic acid (CDCA) and the farnesoid X receptor (FXR)-specific agonist GW4064 strongly induced FGF19 but inhibited CYP7A1 messenger RNA (mRNA) levels in primary human hepatocytes. FGF19 strongly and rapidly repressed CYP7A1 but not small heterodimer partner (SHP) mRNA levels. Kinase inhibition and phosphorylation assays revealed that the mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 (MAPK/Erk1/2) pathway played a major role in mediating FGF19 inhibition of CYP7A1. However, small interfering RNA (siRNA) knockdown of SHP did not affect FGF19 inhibition of CYP7A1. Interestingly, CDCA stimulated tyrosine phosphorylation of the FGF receptor 4 (FGFR4) in hepatocytes. FGF19 antibody and siRNA specific to FGFR4 abrogated GW4064 inhibition of CYP7A1. These results suggest that bile acid-activated FXR is able to induce FGF19 in hepatocytes to inhibit CYP7A1 by an autocrine/paracrine mechanism.
Conclusion:
The hepatic FGF19/FGFR4/Erk1/2 pathway may inhibit CYP7A1 independent of SHP. In addition to inducing FGF19 in the intestine, bile acids in hepatocytes may activate the liver FGF19/FGFR4 signaling pathway to inhibit bile acid synthesis and prevent accumulation of toxic bile acid in human livers.
Insights
Bile acids induce fibroblast growth factor 19 (FGF19) in liver cells, which then inhibits bile acid synthesis by activating the FGF receptor 4 (FGFR4) and Erk1/2 pathway, independent of SHP. This pathway prevents toxic bile acid buildup in human livers.
Area of Science:
- Hepatology
- Endocrinology
- Molecular Biology
Background:
- Fibroblast growth factor 15 (FGF15) and its human ortholog FGF19 are bile acid-induced intestinal factors.
- FGF15/FGF19 mediate feedback inhibition of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription in mouse liver.
- The precise mechanism of FGF15/FGF19 in inhibiting bile acid synthesis in hepatocytes remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which FGF19 inhibits bile acid synthesis in human hepatocytes.
- To investigate the role of the mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 (MAPK/Erk1/2) pathway and FGF receptor 4 (FGFR4) in FGF19 signaling.
Main Methods:
- Primary human hepatocytes were treated with chenodeoxycholic acid (CDCA) or a farnesoid X receptor (FXR) agonist.
- Messenger RNA (mRNA) levels of CYP7A1 and small heterodimer partner (SHP) were measured.
- Kinase inhibition, phosphorylation assays, siRNA knockdown, and antibody neutralization were employed to study signaling pathways.
Main Results:
- CDCA and the FXR agonist induced FGF19 and inhibited CYP7A1 mRNA levels in hepatocytes.
- FGF19 rapidly repressed CYP7A1 mRNA but not SHP mRNA.
- The MAPK/Erk1/2 pathway was crucial for FGF19-mediated CYP7A1 inhibition.
- CDCA stimulated tyrosine phosphorylation of FGFR4, and FGFR4 inhibition abrogated FGF19's effect on CYP7A1.
Conclusions:
- Hepatic FGF19 signaling via FGFR4 and Erk1/2 inhibits CYP7A1 independently of SHP.
- Bile acids activate an autocrine/paracrine FGF19/FGFR4/Erk1/2 pathway in hepatocytes.
- This pathway serves to inhibit bile acid synthesis and prevent the accumulation of toxic bile acids in human livers.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cell Specific Gene Expression
Cirrhosis II: Pathophysiology
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Introduction to Fibroblasts

